Correlation and Agreement of Yttrium-90 Positron Emission Tomography/Computed Tomography with Ex Vivo Radioembolization Microsphere Deposition in the Rabbit VX2 Liver Tumor Model

Andrew C. Gordon; Vanessa L. Gates; Sarah B. White; Kathleen R. Harris; Daniel Procissi; Zhuoli Zhang; Weiguo Li; Donald Samaan; Jodi R. Nicolai; Samdeep K. Mouli; Kent T. Sato; Robert K. Ryu; Reed A. Omary; Riad Salem; Robert J. Lewandowski; Andrew C. Larson

doi:10.1016/j.jvir.2020.09.016

Correlation and Agreement of Yttrium-90 Positron Emission Tomography/Computed Tomography with Ex Vivo Radioembolization Microsphere Deposition in the Rabbit VX2 Liver Tumor Model

Andrew C. Gordon^*, Vanessa L. Gates, Sarah B. White, Kathleen R. Harris, Daniel Procissi, Zhuoli Zhang, Weiguo Li, Donald Samaan, Jodi R. Nicolai, Samdeep K. Mouli, Kent T. Sato, Robert K. Ryu, Reed A. Omary, Riad Salem, Robert J. Lewandowski, Andrew C. Larson

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Purpose: To demonstrate a stronger correlation and agreement of yttrium-90 (⁹⁰Y) positron emission tomography (PET)/computed tomography (CT) measurements with explant liver tumor dosing compared with the standard model (SM) for radioembolization. Materials and Methods: Hepatic VX2 tumors were implanted into New Zealand white rabbits, with growth confirmed by 7 T magnetic resonance imaging. Seventeen VX2 rabbits provided 33 analyzed tumors. Treatment volumes were calculated from manually drawn volumes of interest (VOI) with three-dimensional surface renderings. Radioembolization was performed with glass ⁹⁰Y microspheres. PET/CT imaging was completed with scatter and attenuation correction. Three-dimensional ellipsoid VOI were drawn to encompass tumors on fused images. Tumors and livers were then explanted for inductively coupled plasma (ICP)-optical emission spectroscopy (OES) analysis of microsphere content. ⁹⁰Y PET/CT and SM measurements were compared with reference standard ICP-OES measurements of tumor dosing with Pearson correlation and Bland-Altman analyses for agreement testing with and without adjustment for tumor necrosis. Results: The median infused activity was 33.3 MBq (range, 5.9–152.9). Tumor dose was significantly correlated with ⁹⁰Y PET/CT measurements (r = 0.903, P < .001) and SM estimates (r = 0.607, P < .001). Bland-Altman analyses showed that the SM tended to underestimate the tumor dosing by a mean of −8.5 Gy (CI, −26.3–9.3), and the degree of underestimation increased to a mean of −18.3 Gy (CI, −38.5–1.9) after the adjustment for tumor necrosis. Conclusions: ⁹⁰Y PET/CT estimates were strongly correlated and had better agreement with reference measurements of tumor dosing than SM estimates.

Original language	English (US)
Pages (from-to)	23-32.e1
Journal	Journal of Vascular and Interventional Radiology
Volume	32
Issue number	1
DOIs	https://doi.org/10.1016/j.jvir.2020.09.016
State	Published - Jan 2021

Funding

A.C.L. received grant funding from BTG (investigator-initiated study). S.B.W. is a consultant for Guerbet and receives research support from Siemens and Guerbet . R.J.L. receives research support from R01CA233878-01. R.J.L. and A.C.G. are consultants for ABK. None of the other authors have identified any conflict of interest. Role of Funding: We are grateful for the generous funding provided by the SIR Foundation Allied Scientist Grant (A.C.G.), the Department of Radiology of the Feinberg School of Medicine , and NIH grant R01CA196967-01 . A.C.G. was also supported by the Medical Scientist Training Program ( T32GM008152 ). R.J.L. receives research support from R01CA233878-01. Dose vials, administration kits, and additional funding for research materials were provided by an investigator-initiated study (IIS) grant from BTG. S.B.W. receives salary support from NIH grant 5R25 CA 132822-03 and the RSNA Foundation Research Scholar Grant. The listed authors performed data collection, analysis, and manuscript preparation independently, without assistance from funding sources. A.C.L. received grant funding from BTG (investigator-initiated study). S.B.W. is a consultant for Guerbet and receives research support from Siemens and Guerbet. R.J.L. receives research support from R01CA233878-01. R.J.L. and A.C.G. are consultants for ABK. None of the other authors have identified any conflict of interest.The authors thank Rudiger Laufhutte for performing microsphere digestion and ICP-OES. The authors thank Northwestern University Health Physics (Jose Macatangay, Joseph Princewill, and Thomas E. Whittenhall Jr.) and Northwestern Memorial Hospital Department of Nuclear Medicine (Mike Zimmer, Scott M. Leonard, Peter Cutrera, Lisa Riehle, MacKenzie King, Antonella Guardioloa, Tory Maloy, and Michelle Gruchot). Animal housing and husbandry were provided by the Center for Comparative Medicine (Stephen I. Levin and Giovanni Pompilio). Imaging for our studies was made possible by Northwestern University's Center for Translational Imaging (Daniel Procissi and Sol Misener). Role of Funding: We are grateful for the generous funding provided by the SIR Foundation Allied Scientist Grant (A.C.G.), the Department of Radiology of the Feinberg School of Medicine, and NIH grant R01CA196967-01. A.C.G. was also supported by the Medical Scientist Training Program (T32GM008152). R.J.L. receives research support from R01CA233878-01. Dose vials, administration kits, and additional funding for research materials were provided by an investigator-initiated study (IIS) grant from BTG. S.B.W. receives salary support from NIH grant 5R25 CA 132822-03 and the RSNA Foundation Research Scholar Grant. The listed authors performed data collection, analysis, and manuscript preparation independently, without assistance from funding sources.

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jvir.2020.09.016

Cite this

Gordon, A. C., Gates, V. L., White, S. B., Harris, K. R., Procissi, D., Zhang, Z., Li, W., Samaan, D., Nicolai, J. R., Mouli, S. K., Sato, K. T., Ryu, R. K., Omary, R. A., Salem, R., Lewandowski, R. J., & Larson, A. C. (2021). Correlation and Agreement of Yttrium-90 Positron Emission Tomography/Computed Tomography with Ex Vivo Radioembolization Microsphere Deposition in the Rabbit VX2 Liver Tumor Model. Journal of Vascular and Interventional Radiology, 32(1), 23-32.e1. https://doi.org/10.1016/j.jvir.2020.09.016

@article{4854c24eab4e410db48490faa0c8e0eb,

title = "Correlation and Agreement of Yttrium-90 Positron Emission Tomography/Computed Tomography with Ex Vivo Radioembolization Microsphere Deposition in the Rabbit VX2 Liver Tumor Model",

abstract = "Purpose: To demonstrate a stronger correlation and agreement of yttrium-90 (90Y) positron emission tomography (PET)/computed tomography (CT) measurements with explant liver tumor dosing compared with the standard model (SM) for radioembolization. Materials and Methods: Hepatic VX2 tumors were implanted into New Zealand white rabbits, with growth confirmed by 7 T magnetic resonance imaging. Seventeen VX2 rabbits provided 33 analyzed tumors. Treatment volumes were calculated from manually drawn volumes of interest (VOI) with three-dimensional surface renderings. Radioembolization was performed with glass 90Y microspheres. PET/CT imaging was completed with scatter and attenuation correction. Three-dimensional ellipsoid VOI were drawn to encompass tumors on fused images. Tumors and livers were then explanted for inductively coupled plasma (ICP)-optical emission spectroscopy (OES) analysis of microsphere content. 90Y PET/CT and SM measurements were compared with reference standard ICP-OES measurements of tumor dosing with Pearson correlation and Bland-Altman analyses for agreement testing with and without adjustment for tumor necrosis. Results: The median infused activity was 33.3 MBq (range, 5.9–152.9). Tumor dose was significantly correlated with 90Y PET/CT measurements (r = 0.903, P < .001) and SM estimates (r = 0.607, P < .001). Bland-Altman analyses showed that the SM tended to underestimate the tumor dosing by a mean of −8.5 Gy (CI, −26.3–9.3), and the degree of underestimation increased to a mean of −18.3 Gy (CI, −38.5–1.9) after the adjustment for tumor necrosis. Conclusions: 90Y PET/CT estimates were strongly correlated and had better agreement with reference measurements of tumor dosing than SM estimates.",

author = "Gordon, {Andrew C.} and Gates, {Vanessa L.} and White, {Sarah B.} and Harris, {Kathleen R.} and Daniel Procissi and Zhuoli Zhang and Weiguo Li and Donald Samaan and Nicolai, {Jodi R.} and Mouli, {Samdeep K.} and Sato, {Kent T.} and Ryu, {Robert K.} and Omary, {Reed A.} and Riad Salem and Lewandowski, {Robert J.} and Larson, {Andrew C.}",

note = "Funding Information: A.C.L. received grant funding from BTG (investigator-initiated study). S.B.W. is a consultant for Guerbet and receives research support from Siemens and Guerbet . R.J.L. receives research support from R01CA233878-01. R.J.L. and A.C.G. are consultants for ABK. None of the other authors have identified any conflict of interest. Funding Information: Role of Funding: We are grateful for the generous funding provided by the SIR Foundation Allied Scientist Grant (A.C.G.), the Department of Radiology of the Feinberg School of Medicine , and NIH grant R01CA196967-01 . A.C.G. was also supported by the Medical Scientist Training Program ( T32GM008152 ). R.J.L. receives research support from R01CA233878-01. Dose vials, administration kits, and additional funding for research materials were provided by an investigator-initiated study (IIS) grant from BTG. S.B.W. receives salary support from NIH grant 5R25 CA 132822-03 and the RSNA Foundation Research Scholar Grant. The listed authors performed data collection, analysis, and manuscript preparation independently, without assistance from funding sources. Funding Information: A.C.L. received grant funding from BTG (investigator-initiated study). S.B.W. is a consultant for Guerbet and receives research support from Siemens and Guerbet. R.J.L. receives research support from R01CA233878-01. R.J.L. and A.C.G. are consultants for ABK. None of the other authors have identified any conflict of interest.The authors thank Rudiger Laufhutte for performing microsphere digestion and ICP-OES. The authors thank Northwestern University Health Physics (Jose Macatangay, Joseph Princewill, and Thomas E. Whittenhall Jr.) and Northwestern Memorial Hospital Department of Nuclear Medicine (Mike Zimmer, Scott M. Leonard, Peter Cutrera, Lisa Riehle, MacKenzie King, Antonella Guardioloa, Tory Maloy, and Michelle Gruchot). Animal housing and husbandry were provided by the Center for Comparative Medicine (Stephen I. Levin and Giovanni Pompilio). Imaging for our studies was made possible by Northwestern University's Center for Translational Imaging (Daniel Procissi and Sol Misener). Role of Funding: We are grateful for the generous funding provided by the SIR Foundation Allied Scientist Grant (A.C.G.), the Department of Radiology of the Feinberg School of Medicine, and NIH grant R01CA196967-01. A.C.G. was also supported by the Medical Scientist Training Program (T32GM008152). R.J.L. receives research support from R01CA233878-01. Dose vials, administration kits, and additional funding for research materials were provided by an investigator-initiated study (IIS) grant from BTG. S.B.W. receives salary support from NIH grant 5R25 CA 132822-03 and the RSNA Foundation Research Scholar Grant. The listed authors performed data collection, analysis, and manuscript preparation independently, without assistance from funding sources.",

year = "2021",

month = jan,

doi = "10.1016/j.jvir.2020.09.016",

language = "English (US)",

volume = "32",

pages = "23--32.e1",

journal = "Journal of Vascular and Interventional Radiology",

issn = "1051-0443",

publisher = "Elsevier Inc.",

number = "1",

}

Gordon, AC, Gates, VL, White, SB, Harris, KR, Procissi, D, Zhang, Z, Li, W, Samaan, D, Nicolai, JR, Mouli, SK , Sato, KT, Ryu, RK, Omary, RA, Salem, R , Lewandowski, RJ & Larson, AC 2021, 'Correlation and Agreement of Yttrium-90 Positron Emission Tomography/Computed Tomography with Ex Vivo Radioembolization Microsphere Deposition in the Rabbit VX2 Liver Tumor Model', Journal of Vascular and Interventional Radiology, vol. 32, no. 1, pp. 23-32.e1. https://doi.org/10.1016/j.jvir.2020.09.016

Correlation and Agreement of Yttrium-90 Positron Emission Tomography/Computed Tomography with Ex Vivo Radioembolization Microsphere Deposition in the Rabbit VX2 Liver Tumor Model. / Gordon, Andrew C.; Gates, Vanessa L.; White, Sarah B. et al.
In: Journal of Vascular and Interventional Radiology, Vol. 32, No. 1, 01.2021, p. 23-32.e1.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Correlation and Agreement of Yttrium-90 Positron Emission Tomography/Computed Tomography with Ex Vivo Radioembolization Microsphere Deposition in the Rabbit VX2 Liver Tumor Model

AU - Gordon, Andrew C.

AU - Gates, Vanessa L.

AU - White, Sarah B.

AU - Harris, Kathleen R.

AU - Procissi, Daniel

AU - Zhang, Zhuoli

AU - Li, Weiguo

AU - Samaan, Donald

AU - Nicolai, Jodi R.

AU - Mouli, Samdeep K.

AU - Sato, Kent T.

AU - Ryu, Robert K.

AU - Omary, Reed A.

AU - Salem, Riad

AU - Lewandowski, Robert J.

AU - Larson, Andrew C.

N1 - Funding Information: A.C.L. received grant funding from BTG (investigator-initiated study). S.B.W. is a consultant for Guerbet and receives research support from Siemens and Guerbet . R.J.L. receives research support from R01CA233878-01. R.J.L. and A.C.G. are consultants for ABK. None of the other authors have identified any conflict of interest. Funding Information: Role of Funding: We are grateful for the generous funding provided by the SIR Foundation Allied Scientist Grant (A.C.G.), the Department of Radiology of the Feinberg School of Medicine , and NIH grant R01CA196967-01 . A.C.G. was also supported by the Medical Scientist Training Program ( T32GM008152 ). R.J.L. receives research support from R01CA233878-01. Dose vials, administration kits, and additional funding for research materials were provided by an investigator-initiated study (IIS) grant from BTG. S.B.W. receives salary support from NIH grant 5R25 CA 132822-03 and the RSNA Foundation Research Scholar Grant. The listed authors performed data collection, analysis, and manuscript preparation independently, without assistance from funding sources. Funding Information: A.C.L. received grant funding from BTG (investigator-initiated study). S.B.W. is a consultant for Guerbet and receives research support from Siemens and Guerbet. R.J.L. receives research support from R01CA233878-01. R.J.L. and A.C.G. are consultants for ABK. None of the other authors have identified any conflict of interest.The authors thank Rudiger Laufhutte for performing microsphere digestion and ICP-OES. The authors thank Northwestern University Health Physics (Jose Macatangay, Joseph Princewill, and Thomas E. Whittenhall Jr.) and Northwestern Memorial Hospital Department of Nuclear Medicine (Mike Zimmer, Scott M. Leonard, Peter Cutrera, Lisa Riehle, MacKenzie King, Antonella Guardioloa, Tory Maloy, and Michelle Gruchot). Animal housing and husbandry were provided by the Center for Comparative Medicine (Stephen I. Levin and Giovanni Pompilio). Imaging for our studies was made possible by Northwestern University's Center for Translational Imaging (Daniel Procissi and Sol Misener). Role of Funding: We are grateful for the generous funding provided by the SIR Foundation Allied Scientist Grant (A.C.G.), the Department of Radiology of the Feinberg School of Medicine, and NIH grant R01CA196967-01. A.C.G. was also supported by the Medical Scientist Training Program (T32GM008152). R.J.L. receives research support from R01CA233878-01. Dose vials, administration kits, and additional funding for research materials were provided by an investigator-initiated study (IIS) grant from BTG. S.B.W. receives salary support from NIH grant 5R25 CA 132822-03 and the RSNA Foundation Research Scholar Grant. The listed authors performed data collection, analysis, and manuscript preparation independently, without assistance from funding sources.

PY - 2021/1

Y1 - 2021/1

N2 - Purpose: To demonstrate a stronger correlation and agreement of yttrium-90 (90Y) positron emission tomography (PET)/computed tomography (CT) measurements with explant liver tumor dosing compared with the standard model (SM) for radioembolization. Materials and Methods: Hepatic VX2 tumors were implanted into New Zealand white rabbits, with growth confirmed by 7 T magnetic resonance imaging. Seventeen VX2 rabbits provided 33 analyzed tumors. Treatment volumes were calculated from manually drawn volumes of interest (VOI) with three-dimensional surface renderings. Radioembolization was performed with glass 90Y microspheres. PET/CT imaging was completed with scatter and attenuation correction. Three-dimensional ellipsoid VOI were drawn to encompass tumors on fused images. Tumors and livers were then explanted for inductively coupled plasma (ICP)-optical emission spectroscopy (OES) analysis of microsphere content. 90Y PET/CT and SM measurements were compared with reference standard ICP-OES measurements of tumor dosing with Pearson correlation and Bland-Altman analyses for agreement testing with and without adjustment for tumor necrosis. Results: The median infused activity was 33.3 MBq (range, 5.9–152.9). Tumor dose was significantly correlated with 90Y PET/CT measurements (r = 0.903, P < .001) and SM estimates (r = 0.607, P < .001). Bland-Altman analyses showed that the SM tended to underestimate the tumor dosing by a mean of −8.5 Gy (CI, −26.3–9.3), and the degree of underestimation increased to a mean of −18.3 Gy (CI, −38.5–1.9) after the adjustment for tumor necrosis. Conclusions: 90Y PET/CT estimates were strongly correlated and had better agreement with reference measurements of tumor dosing than SM estimates.

AB - Purpose: To demonstrate a stronger correlation and agreement of yttrium-90 (90Y) positron emission tomography (PET)/computed tomography (CT) measurements with explant liver tumor dosing compared with the standard model (SM) for radioembolization. Materials and Methods: Hepatic VX2 tumors were implanted into New Zealand white rabbits, with growth confirmed by 7 T magnetic resonance imaging. Seventeen VX2 rabbits provided 33 analyzed tumors. Treatment volumes were calculated from manually drawn volumes of interest (VOI) with three-dimensional surface renderings. Radioembolization was performed with glass 90Y microspheres. PET/CT imaging was completed with scatter and attenuation correction. Three-dimensional ellipsoid VOI were drawn to encompass tumors on fused images. Tumors and livers were then explanted for inductively coupled plasma (ICP)-optical emission spectroscopy (OES) analysis of microsphere content. 90Y PET/CT and SM measurements were compared with reference standard ICP-OES measurements of tumor dosing with Pearson correlation and Bland-Altman analyses for agreement testing with and without adjustment for tumor necrosis. Results: The median infused activity was 33.3 MBq (range, 5.9–152.9). Tumor dose was significantly correlated with 90Y PET/CT measurements (r = 0.903, P < .001) and SM estimates (r = 0.607, P < .001). Bland-Altman analyses showed that the SM tended to underestimate the tumor dosing by a mean of −8.5 Gy (CI, −26.3–9.3), and the degree of underestimation increased to a mean of −18.3 Gy (CI, −38.5–1.9) after the adjustment for tumor necrosis. Conclusions: 90Y PET/CT estimates were strongly correlated and had better agreement with reference measurements of tumor dosing than SM estimates.

UR - http://www.scopus.com/inward/record.url?scp=85096171405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096171405&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2020.09.016

DO - 10.1016/j.jvir.2020.09.016

M3 - Article

C2 - 33189539

AN - SCOPUS:85096171405

SN - 1051-0443

VL - 32

SP - 23-32.e1

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

IS - 1

ER -

Correlation and Agreement of Yttrium-90 Positron Emission Tomography/Computed Tomography with Ex Vivo Radioembolization Microsphere Deposition in the Rabbit VX2 Liver Tumor Model

Abstract

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this